MSH2 and neoplasm: BRCA1 vs BRCA2 tumours (Figure 5b): We observed a lower co-expression for the MMR complex MLH1-MSH6-MSH2-PMS2-PCNA in BRCA1 tumours compared to BRCA2 tumours; we think this is due to the parallel roles of BRCA1.